Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2Article Published on 2024-12-312024-09-02 Journal: Pharmeur Bio Sci Notes [Category] 파상풍, [키워드] European Pharmacopoeia international standard potency Quality control reference standard Tetanus immunoglobulin PMC 바로가기
Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2Article Published on 2024-12-312024-09-02 Journal: Pharmeur Bio Sci Notes [Category] 파상풍, [키워드] European Pharmacopoeia international standard potency Quality control reference standard Tetanus immunoglobulin PMC 바로가기
Evaluating diagnostic accuracies of Panbio™ test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM)Article Published on 2022-10-192022-11-15 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Accuracy Ag-RDTs Bayesian clinical setting cough COVID-19 COVID-19 pandemic CrI criteria cross-sectional diagnostic diagnostic sensitivity diagnostics enrolled evaluate Evaluating exhibited expected females health center hospitals individual majority Model MOST pandemic Patient performed positive positive RT-PCR Rapid rapid antigen test Rapid diagnostic test reference standard reported RT-PCR SARS-CoV-2 sensitivity specificity Study participants symptomatic and asymptomatic the WHO Transmission was done without symptoms [DOI] 10.1371/journal.pone.0268160 PMC 바로가기
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR StudiesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 치료제, [키워드] addition Anticoagulant Anticoagulants carried Compound compounds conducted COVID-19 cytotoxicity demonstrated drug Dynamics eligible enzyme highest highest binding affinity Idraparinux in silico in silico approaches in vitro inhibitory inhibitory activity inhibitory concentration intrinsic investigated M pro molecular molecular docking MPro MTT performed Potential protease reference standard SAR SARS-CoV-2 SARS-CoV-2 Mpro screened sodium the SARS-CoV-2 thermodynamic [DOI] 10.3390/ijms232012235 PMC 바로가기
Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in PeruArticle Published on 2022-08-312022-11-16 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술, [키워드] analyzed Antigen assessment asymptomatic individual calculated Care community transmission COVID-19 COVID-19 pandemic cycle threshold Cycle threshold value detection Diagnosis diagnostic enrolled Frequency Health nasopharyngeal Nasopharyngeal swab nasopharyngeal swab specimen Nasopharyngeal swab specimens nasopharynx noninvasive technique North participant performance performed Peru Predictive public health pulse oximetry reference standard reverse transcription PCR RT-PCR RT-PCR diagnosis Saliva SARS-CoV-2 Screening SD Biosensor seeking sensitivity Sensitivity and specificity specificity Symptom symptom onset symptomatic individuals threshold validation validation study Viral load [DOI] 10.1128/spectrum.00861-22 PMC 바로가기
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination감염 또는 백신 접종 후 T-세포 반응의 간단한 검출을 위한 표준화된 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 인터페론-γ 방출 분석의 임상 성능Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료기술, [키워드] 19 2 95% confidence interval Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 best Cell cell response Chain Reaction clinical convalescent Convalescent patients coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 CoV COVID COVID-19 dependent on detection disease severity Euroimmun evaluated Follow-up Germany healthy IFN-γ IFN-γ response IFN-γ responses IGRA immune response individual Infection interferon interferon-γ magnitude Mild disease mild infections Neutralizing antibodies neutralizing antibody Patient performance polymerase chain reaction positive Primary infection Prospective Study Quantitative reference standard Release respiratory response reverse transcription Reverse transcription-polymerase chain reaction SARS SARS-CoV-2 SARS-COV-2 infection sensitivity serological serological test Serological tests serology severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe COVID-19 severity severity of illness simple specificity subject subjects T T-cell T-cell Response uninfected vaccination was measured Whole blood with mild disease γ release assay. [DOI] 10.1093/cid/ciab1021 PMC 바로가기 [Article Type] Article
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infectionSARS-CoV-2 감염 진단을 위한 신속한 현장 진료 항원 검사Review Published on 2022-07-222022-09-11 Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제, [키워드] 95% CI 95% confidence interval absence access Accuracy age Antigen antigen test antigen tests approach assays Asymptomatic average Bern bioRxiv brand can not carried Chain Reaction Characteristics checked CIs Cohort Compliance conducted COVID-19 COVID-19 pandemic COVID-19 testing criteria criterion Data collection database demonstrated described detect diagnosis of SARS-CoV-2 diagnostic Diagnostic accuracy diagnostic tests Effectiveness eligible epidemiological estimate Europe evaluate evaluated Evidence exposure to False positive False positives global health groups Health Organization healthcare help heterogeneity highest include independent indication Infection Interpretation investigated logistic regression models management Mass screening measure medRxiv molecular test National Open Access Other participant Participants Patient care point-of-care polymerase chain polymerase chain reaction population groups Positive predictive value positive result PPV Predictive value presence or absence Prevalence produced public health QUADAS-2 random-effect ranged Rapid rapid antigen test Rapid antigen tests Rapid diagnostic test reduce reducing reference reference standard Reference standards repeated reported Research respiratory respiratory sample resulting reverse transcription reverse transcription polymerase chain reaction RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection Schools screened screening procedure screening programmes searched second Selection sensitivities sensitivity Sensitivity and specificity Seven Signs and symptoms Source Specificities specificity study cohort Study design Symptom symptom onset symptom status symptomatic symptomatic and asymptomatic symptomatic participant symptomatic participants symptomatic people symptoms of COVID-19 test negative test result Testing to define Transmission Triage unique University of Bern variable Viral Viral load viral loads website were used WHO World Health Organization [DOI] 10.1002/14651858.CD013705.pub3 PMC 바로가기 [Article Type] Review
Recommendations for achieving interoperable and shareable medical data in the USA Reviews Published on 2022-07-182022-10-05 Journal: Communications Medicine [Category] 유전자 메커니즘, 진단, [키워드] binding changes in effort evaluate Health implementation information laboratory result Patient Prevent public health measure reference standard required Support Transmission USA [DOI] 10.1038/s43856-022-00148-x [Article Type] Reviews
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay(COVID-19) NOW 식별 능력 평가: Abbott ID NOW COVID-19 분석에 대한 대규모 실제 전향적 평가Article Published on 2022-06-292022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Abbott Ability Admitted Patient admitted patients Affect applicability assist Canada chain changed Cohort Community COVID-19 COVID-19 admission Critical decrease disease dual epidemiological evaluated Evaluating facilitate Factor Factors false negatives False positive highest hospital ID NOW increase in individual infection control Laboratory limitation molecular test multisite Negative predictive value not high pandemic Patient patient cohorts POCT point-of-care positive predictive values presenting Prevalence Probability Prospective public health Rapid Rapid test rapid testing Rapid tests receipt reduced reference standard report Reporting reverse transcriptase reverse transcriptase PCR risk RT-PCR SARS-CoV-2 SARS-CoV-2 detection status Study design swabs symptom onset TAT theory Tolerance Transmission Triage true negative turnaround time turnaround times utility Variation variations Volume [DOI] 10.1128/spectrum.00513-22 PMC 바로가기 [Article Type] Article
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 20212020년 4월부터 2021년 3월까지 헌혈자 보유 표본에서 일반적으로 사용되는 캐나다 SARS-CoV-2 효소 면역분석에 대한 Abbott SARS-CoV-2 IgG II 정량 분석의 정성적 비교Article Published on 2022-06-292022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료법, [키워드] 95% CI 95% confidence interval Abbott Abbott SARS-CoV-2 IgG aggregate Analysis analyzed anti-S anti-SARS-CoV-2 anti-SARS-CoV-2 IgG Anti-spike antibody approach assays Blood donors can be used Canada Characteristics characterized Chicago collected detect ELISAs enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays full-length spike glycoprotein glycoprotein gold gold standard house identify IgG IgG response IgG responses Laboratory methods comparisons nucleocapsid positive provide Qualitative qualitative test RBD Receptor binding Receptor binding domain recognizing reference standard Research retention SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antigens SARS-CoV-2 variant scored sensitivity serology Seropositivity specificity specimen spike spike glycoprotein standard error the SARS-CoV-2 the strongest threshold viral antigens wild-type [DOI] 10.1128/spectrum.01134-22 PMC 바로가기 [Article Type] Article